Oral drug for MS significantly reduces disease activity and slows disability
Monday, April 11, 2011 - 16:31
in Health & Medicine
The drug laquinimod reduced the number of relapses for people with multiple sclerosis (MS), in a large, long-term Phase III clinical study that will be presented as late-breaking research at the 63rd Annual Meeting of the American Academy of Neurology, April 9-16, 2011, in Honolulu.